ArticleBreast cancer research and treatment2020

The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer.

Rokaya El Ansari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.